LGALS3BP and atherosclerosis: To test this hypothesis, we conducted in vivo and in vitro experiments which showed that in the liver of MAFLD model mice and FFA‐treated hepatocytes and EVs derived therefrom, Lgals3bp was significantly up‐regulated, while the knockdown of Lgals3bp alleviated MAFLD‐related arterial calcification and atherosclerosis.